- Report
- March 2024
- 188 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- April 2024
- 173 Pages
Global
From €4787EUR$4,950USD£4,103GBP
- Report
- December 2023
- 172 Pages
Global
€4830EUR$4,995USD£4,140GBP
- Report
- February 2024
- 110 Pages
Global
From €4594EUR$4,750USD£3,937GBP
- Report
- March 2022
- 120 Pages
Global
From €2418EUR$2,500USD£2,072GBP
- Report
- May 2023
- 100 Pages
Global
From €3500EUR$3,877USD£3,105GBP
The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more